A new study co-authored by MCB, Chemistry & NST Associate Professor Dan Nomura investigates how nimbolide, a natural product derived from the neem tree, may function in impairing cancer pathogenicity.
“We discover here that nimbolide not only impairs cancer pathogenicity through stabilizing tumor suppressors, but that we can exploit nimbolide to also degrade and eliminate other cancer-causing proteins in cells for cancer therapy,” said Nomura.